Alzheimer's dementia, often simply referred to as Alzheimer's, is a progressive neurodegenerative disorder affecting the brain. It is the most common form of dementia, accounting for a significant majority of dementia cases. Alzheimer's disease primarily impacts cognitive functions, memory, and behavior, leading to a decline in the individual's ability to carry out daily activities.

The exact cause of Alzheimer's is not fully understood, but it is associated with the accumulation of abnormal protein deposits in the brain, including beta-amyloid plaques and tau tangles. Genetic, environmental, and lifestyle factors may also contribute.

Key Features of Alzheimer's Dementia

• Memory Loss: One of the hallmark symptoms is difficulty remembering recent events or retaining new information.
• Cognitive Decline: Individuals with Alzheimer's experience a gradual decline in thinking abilities, including reasoning, problem-solving, and decision-making.
• Language Difficulties: Difficulty finding the right words, understanding conversations, or expressing oneself verbally.
• Disorientation: Confusion about time, place, and familiar surroundings is common. Individuals may get lost even in familiar settings.
• Mood and Personality Changes: Alzheimer's can lead to mood swings, increased irritability, and changes in personality.

Major statistics on Alzheimer’s Dementia

1. 6 million Americans are currently living with Alzheimer's, with an estimated 6.7 million aged 65 and older affected in 2023.
2. Every 3 seconds, someone in the world develops dementia.
3. 55 million people worldwide had dementia in 2020, expected to rise to 139 million by 2050.
4. 38% of Alzheimer's cases in the U.S. are in individuals aged 75-84, with 27% in those aged 65-74.
5. Women represent over 60% of Alzheimer's cases in the U.S., largely due to longer life expectancy.
6. 18.6% of Black Americans aged 65 and older have Alzheimer's, compared to 14% of Hispanic Americans and 10% of non-Hispanic White Americans.
7. 62% of Alzheimer's patients are prescribed cholinesterase inhibitors to manage symptoms.
8. 1 in 3 seniors will develop Alzheimer's or another form of dementia, and Alzheimer's causes more deaths among seniors than both breast cancer and prostate cancer combined.

How many people have Alzheimer’s Dementia?

• Statistics from the Alzheimer’s Association shows that over 6 million Americans, spanning various age groups, are currently dealing with Alzheimer's. 
• In 2023, an estimated 6.7 million Americans aged 65 and older are living with Alzheimer's. 
• Information from the Alzheimer’s Disease Association shows that every 3 seconds, someone in the world develops dementia. 
• In 2020, more than 55 million people worldwide were living with dementia. This number is expected to almost double every 20 years, reaching 78 million in 2030 and a whopping 139 million in 2050. Most of the increase will happen in developing countries. 

Alzheimer’s Dementia statistics by age

• Information from Statista shows that Alzheimer’s dementia is most common in seniors between 75-84 years. 
• In the United States, approximately 38 percent of individuals diagnosed with Alzheimer's fall within the age range of 75 to 84 years. Additionally, around 27 percent of those affected by Alzheimer's fall within the age group of 65 to 74 years. 

Alzheimer’s Dementia statistics by gender 

• Women face a higher likelihood of developing dementia over their lifetime, with nearly double the number of women diagnosed with Alzheimer's disease, the most prevalent form of dementia, in comparison to men. This elevated risk can be attributed primarily to the fact that women tend to live longer than men, and advanced age stands as the most significant risk factor for the onset of this disease.

Alzheimer’s statistics by causes

• Age: Age is the most significant risk factor, with nearly one-third of individuals aged 85 and older affected by Alzheimer’s. About one in 13 people aged 65 to 84 also live with the disease.
• Genetics: Certain genetic factors increase the risk Alzheimer’s dementia. For example, individuals carrying the APOE ε4 allele have a higher chance of developing Alzheimer’s, and rare genetic mutations in the APP, PSEN1, and PSEN2 genes can cause early-onset Alzheimer’s, typically before age 65.
• Health Conditions: Vascular conditions like heart disease, stroke, and high blood pressure are associated with a higher likelihood of developing Alzheimer’s. Metabolic issues such as diabetes and obesity also elevate the risk.
• Gender: Women are disproportionately affected, representing over 60% of Alzheimer’s cases in the U.S., partly due to their longer life expectancy.
• Race: Alzheimer’s prevalence varies by ethnicity, with Black Americans having the highest rate among older adults at about 18.6%, compared to 14% among Hispanic Americans and 10% among non-Hispanic White Americans.

Alzheimer’s statistics by country 

• United States: In the U.S., approximately 6.7 million Americans aged 65 and older are living with Alzheimer's disease. By 2060, this number is projected to grow to 13.8 million.
• Europe: Europe has about 10 million people with dementia, a number that is expected to rise significantly in the coming decades.
• Asia: Countries like China and India are seeing rapid increases in dementia cases. By 2050, 72% of dementia cases are projected to be in low- and middle-income countries, particularly in Asia.
• United Kingdom: The UK currently has about 900,000 people with dementia. This number is expected to increase to 1.6 million by 2040.
• Latin America: In countries like Brazil, more than 1.5 million people are estimated to have dementia, with numbers continuing to rise.

Alzheimer’ statistics by Treatment

• Medication Use: About 62% of patients with Alzheimer's are prescribed cholinesterase inhibitors (like Donepezil, Rivastigmine, and Galantamine) to help manage symptoms, especially in the early to mid-stages. 

• Efficacy of Current Treatments: Current medications for Alzheimer's do not cure the disease but can reduce symptoms. These treatments generally provide limited benefits that last 6 to 12 months for about 50% of individuals. Clinical trials are exploring the efficacy of combination therapies, aiming to provide more substantial improvements.
• Research Developments: Significant investment is being made into research for disease-modifying therapies. In 2023, global spending on Alzheimer’s research reached over $3 billion, with many studies focusing on targeting amyloid plaques, tau proteins, and inflammation. In recent years, there have been approvals for new drugs, such as Aducanumab and Lecanemab, which target beta-amyloid plaques, showing a potential to slow disease progression in early stages.
• Non-Medical Treatments: Approximately 60% of patients use non-drug therapies, including cognitive behavioral therapy, exercise, and diet adjustments (like the Mediterranean diet) to slow cognitive decline.

Number of deaths caused by Alzheimer’s Dementia

• One out of every three seniors faces Alzheimer's or another form of dementia, showing how common these conditions are among older adults. What's even more striking is that Alzheimer's causes more deaths among seniors than both breast cancer and prostate cancer combined. This highlights the urgent need for better understanding, care, and prevention strategies, especially as our population continues to age.

Frequently asked questions

Sources

• Alzheimer's Disease International. Dementia statistics. Alzheimer’s Disease International. Retrieved November 18, 2024, from https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/#:~:text=Someone%20in%20the%20world%20develops,will%20be%20in%20developing%20countries
• Statista. (2021, August 11). Share of Alzheimer's disease patients by age group in the U.S. Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/452911/share-of-alzheimers-disease-patients-by-age-group-in-the-us/
• National Institute on Aging. (2023, June 26). What causes Alzheimer’s disease? National Institute on Aging. Retrieved November 18, 2024, from https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-causes-alzheimers-disease#:~:text=Aging%20and%20Alzheimer%27s%20risk,-Age%20is%20the&text=As%20a%20person%20ages%20past,it%20largely%20affects%20older%20adults
• National Institute on Aging. (2023, May 4). Alzheimer's disease genetics fact sheet. National Institute on Aging. Retrieved November 18, 2024, from https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/alzheimers-disease-genetics-fact-sheet#:~:text=One%20well%2Dknown%20gene%20that%20influences%20Alzheimer%E2%80%99s%20risk%20is%20the%20apolipoprotein%20E%20(APOE)%20gene
• Lee, S. E., et al. (2020). Prevalence and ethnic differences of Alzheimer's disease and related dementias in the United States. Journal of Alzheimer's Disease, 75(2), 611-620. https://doi.org/10.3233/JAD-200519
• Alzheimer's Europe. (2023, September 19). Prevalence of dementia in Europe. Alzheimer’s Europe. Retrieved November 18, 2024, from https://www.alzheimer-europe.org/dementia/prevalence-dementia-europe?language_content_entity=en#:~:text=Europe%27s%20population%20is,born%20in%202019
• Alzheimer's Disease International. Dementia statistics. Alzheimer’s Disease International. Retrieved November 18, 2024, from https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/#:~:text=Someone%20in%20the,western%20Pacific%20neighbours
• National Health Service. (2024, April 11). What is dementia? NHS. Retrieved November 18, 2024, from https://www.nhs.uk/conditions/dementia/about-dementia/what-is-dementia/#:~:text=How%20common%20is%20dementia,have%20dementia%20in%20the%20UK
• Alzheimer’s Society. (2024, September 10). How many people have dementia in the UK? Alzheimer's Society. Retrieved November 18, 2024, from https://www.alzheimers.org.uk/blog/how-many-people-have-dementia-uk#:~:text=There%20are%20currently%20estimated%20to%20be%20982%2C000%20people%20with%20dementia%20in%20the%20UK.%20This%20number%20is%20expected%20to%20rise%20to%201.4%20million%20by%202040
• Revista Pesquisa. (2020, May 19). At least 1.76 million people in Brazil suffer from dementia. FAPESP. Retrieved November 18, 2024, from https://revistapesquisa.fapesp.br/en/at-least-1-76-million-people-in-brazil-suffer-from-dementia/
• Cummings, J. L., et al. (2020). Medication use in Alzheimer's disease. Neurology, 94(18), e1916-e1924. https://doi.org/10.1212/WNL.0000000000011832#:~:text=Among%20ChEI%20users%2C%20donepezil%20accounted%20for%2062%25%20prescriptions%2C%20followed%20by%20galantamine%20(21%25)%20and%20rivastigmine%20(17%25)

• Mayo Clinic. (2024, February 16). Alzheimer's disease. Mayo Clinic. Retrieved November 18, 2024, from https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048103